Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New indications discovered for Ligand's retinoid compound, Targretin

Sep. 20, 1996

Immunex issued first patent on blood stem cell factor

Sep. 20, 1996

New indication claimed for EPO

Sep. 20, 1996

NPY antagonists from Glaxo Wellcome

Sep. 20, 1996

Bristol-Myers sets up program for heart attack prevention

Sep. 20, 1996

Pierre Fabre investigates ACAT inhibitors

Sep. 20, 1996

Prevention of bone loss with alendronate

Sep. 20, 1996

Endocrine research at Toyama

Sep. 13, 1996

Endocrine R&D at Chugai

Sep. 13, 1996

A safe, effective and economical contraceptive method

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...